Digital Look

Welcome to Digital Look++,
you are not logged in

Alexion Pharmaceuticals Inc. (ALXN)

$ 0.00

Alexion Pharmaceuticals To Report Fourth Quarter...	12-Jan-2009	PR Newswire
Alexion to Present at the 27th Annual JP Morgan ...	05-Jan-2009	PR Newswire
Soliris(R) Reduced Measures of Thrombosis and In...	09-Dec-2008	PR Newswire
Alexion Reports Positive Results from AEGIS Regi...	08-Dec-2008	PR Newswire
First Clinical Experience With Soliris(R) in Tre...	07-Dec-2008	PR Newswire
Alexion to Present at the 20th Annual Piper Jaff...	25-Nov-2008	PR Newswire
Alexion to Present at the 20th Annual Piper Jaff...	25-Nov-2008	PR Newswire
Researchers to Present Additional Data on Soliri...	10-Nov-2008	PR Newswire
Alexion to Present at Investor Conferences	04-Nov-2008	PR Newswire
Alexion Pharmaceuticals Invites You to Participa...	08-Oct-2008	PR Newswire
Alexion's Soliris(R) Receives 2008 Prix Galien U...	25-Sep-2008	PR Newswire
Alexion to Present at the UBS Global Life Scienc...	16-Sep-2008	PR Newswire
Alexion to Present at the Morgan Stanley Global ...	02-Sep-2008	PR Newswire
Alexion Secures U.S. Patent for ALXN6000, a Firs...	07-Aug-2008	PR Newswire
Alexion Reports Second Quarter 2008 Results	29-Jul-2008	PR Newswire
Alexion Pharmaceuticals Invites You to Participa...	10-Jul-2008	PR Newswire
Alexion to Present at the Jefferies & Co. 2n...	18-Jun-2008	PR Newswire
Soliris(R) Improved Fatigue Independent of Chang...	15-Jun-2008	PR Newswire
Alexion to Present at the William Blair 28th Ann...	13-Jun-2008	PR Newswire
Alexion to Present at the Goldman Sachs 29th Ann...	05-Jun-2008	PR Newswire